Rito Bergemann, MD, PhD, MBA

Rito leads the HEOR team with a holistic view to be part of the wider RWE & Access Consulting group. He and his team helps clients get health technologies / drugs onto worldwide markets with a positive and best achievable reimbursement decision.

Work experience

Prior to joining Parexel, Rito held leadership roles in CROs in the field of HEOR including, RWE and Network Meta-Analysis on an international scale. He was responsible for HEOR of Rare Diseases at GSK and the main architect of the health economic and evidence generation program for Humira at Abbott/AbbVie. Rito was also an Adviser for a Hedge Fund focused on biologics and gene therapies.

Education

Rito is a Physician by training at the University Christian-Albrecht Kiel, and RWTH Aachen both in Germany. He is EU certified for medical practising and holds a Ph.D. in transplantational medicine, MBA at Steinbeis University, Berlin.